| Inhaled Insulin - 'Transition' Programme Put In Place, UK |
|
|
|
|
Following talks with Diabetes UK, Pfizer has announced that it is putting in place an extended 'transition' programme to supply Exubera (inhaled insulin) for a up to 12 further months, depending on existing stock levels and expiry dates. [click link for full article] Read more at: http://www.medicalnewstoday.com/articles/91860.php. |